Advertisement
Screener

Five Prime Therapeutics, Inc. Share-based Payment Arrangement, Expense

Five Prime Therapeutics, Inc. Share-based Payment Arrangement, Expense

Five Prime Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $10.19 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-03-22

  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2020-12-31 was $1.47M, a 57.21% decline year-over-year.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $2.06M, a 76.19% decline year-over-year.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $2.18M, a 62.84% decline year-over-year.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2020-03-31 was $4.48M, a 8.00% decline year-over-year.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $10.19M, a 55.35% decline from fiscal 2019.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2019 was $22.82M, a 22.58% decline from fiscal 2018.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2018 was $29.47M, a 13.77% decline from fiscal 2017.
  • Five Prime Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2017 was $34.17M, a 3.92% increase from fiscal 2016.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2020-12-31$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$3.53M
derived: sum of 2 quarters · filed 2021-03-22
$5.71M
derived: sum of 3 quarters · filed 2021-03-22
$10.19M
10-K · filed 2021-03-22
2020-09-30$2.06M
10-Q · filed 2020-11-03
$4.24M
derived: sum of 2 quarters · filed 2020-11-03
$8.72M
10-Q · filed 2020-11-03
$12.15M
derived: sum of 4 quarters · filed 2021-03-22
2020-06-30$2.18M
10-Q · filed 2020-08-06
$6.66M
10-Q · filed 2020-08-06
$10.09M
derived: sum of 3 quarters · filed 2021-03-22
$18.74M
derived: sum of 4 quarters · filed 2021-03-22
2020-03-31$4.48M
10-Q · filed 2020-05-07
$7.91M
derived: sum of 2 quarters · filed 2021-03-22
$16.56M
derived: sum of 3 quarters · filed 2021-03-22
$22.43M
derived: sum of 4 quarters · filed 2021-03-22
2019-12-31$3.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$12.08M
derived: sum of 2 quarters · filed 2021-03-22
$17.94M
derived: sum of 3 quarters · filed 2021-03-22
$22.82M
10-K · filed 2021-03-22
2019-09-30$8.66M
10-Q · filed 2020-11-03
$14.52M
derived: sum of 2 quarters · filed 2020-11-03
$19.39M
10-Q · filed 2020-11-03
$25.97M
derived: sum of 4 quarters · filed 2021-03-22
2019-06-30$5.86M
10-Q · filed 2020-08-06
$10.73M
10-Q · filed 2020-08-06
$17.32M
derived: sum of 3 quarters · filed 2021-03-22
$24.95M
derived: sum of 4 quarters · filed 2021-03-22
2019-03-31$4.87M
10-Q · filed 2020-05-07
$11.45M
derived: sum of 2 quarters · filed 2021-03-22
$19.08M
derived: sum of 3 quarters · filed 2021-03-22
$26.52M
derived: sum of 4 quarters · filed 2021-03-22
2018-12-31$6.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22
$14.21M
derived: sum of 2 quarters · filed 2021-03-22
$21.65M
derived: sum of 3 quarters · filed 2021-03-22
$29.47M
10-K · filed 2021-03-22
2018-09-30$7.63M
10-Q · filed 2019-11-06
$15.07M
derived: sum of 2 quarters · filed 2019-11-06
$22.89M
10-Q · filed 2019-11-06
$30.35M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$7.43M
10-Q · filed 2019-08-08
$15.26M
10-Q · filed 2019-08-08
$22.72M
derived: sum of 3 quarters · filed 2020-02-27
$29.78M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$7.82M
10-Q · filed 2019-05-09
$15.28M
derived: sum of 2 quarters · filed 2020-02-27
$22.34M
derived: sum of 3 quarters · filed 2020-02-27
$32.11M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$7.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$14.53M
derived: sum of 2 quarters · filed 2020-02-27
$24.29M
derived: sum of 3 quarters · filed 2020-02-27
$34.17M
10-K · filed 2020-02-27
2017-09-30$7.06M
10-Q · filed 2018-11-06
$16.82M
derived: sum of 2 quarters · filed 2018-11-06
$26.71M
10-Q · filed 2018-11-06
$36.76M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$9.76M
10-Q · filed 2018-08-08
$19.65M
10-Q · filed 2018-08-08
$29.70M
derived: sum of 3 quarters · filed 2019-02-26
$38.01M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$9.89M
10-Q · filed 2018-05-08
$19.93M
derived: sum of 2 quarters · filed 2019-02-26
$28.25M
derived: sum of 3 quarters · filed 2019-02-26
$35.37M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$10.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$18.36M
derived: sum of 2 quarters · filed 2019-02-26
$25.48M
derived: sum of 3 quarters · filed 2019-02-26
$32.88M
10-K · filed 2019-02-26
2016-09-30$8.31M
10-Q · filed 2017-11-06
$15.44M
derived: sum of 2 quarters · filed 2017-11-06
$22.84M
10-Q · filed 2017-11-06
$29.25M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$7.13M
10-Q · filed 2017-08-08
$14.53M
10-Q · filed 2017-08-08
$20.94M
derived: sum of 3 quarters · filed 2018-02-27
$23.79M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$7.40M
10-Q · filed 2017-05-05
$13.81M
derived: sum of 2 quarters · filed 2018-02-27
$16.66M
derived: sum of 3 quarters · filed 2018-02-27
$17.88M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$6.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$9.26M
derived: sum of 2 quarters · filed 2018-02-27
$10.48M
derived: sum of 3 quarters · filed 2018-02-27
$11.47M
10-K · filed 2018-02-27
2015-09-30$2.85M
10-Q · filed 2016-11-04
$4.07M
derived: sum of 2 quarters · filed 2016-11-04
$5.06M
10-Q · filed 2016-11-04
$6.24M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$1.21M
10-Q · filed 2016-08-05
$2.20M
10-Q · filed 2016-08-05
$3.39M
derived: sum of 3 quarters · filed 2017-02-24
$4.25M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$991.00K
10-Q · filed 2016-05-06
$2.18M
derived: sum of 2 quarters · filed 2017-02-24
$3.03M
derived: sum of 3 quarters · filed 2017-02-24
$3.77M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$2.04M
derived: sum of 2 quarters · filed 2017-02-24
$2.78M
derived: sum of 3 quarters · filed 2017-02-24
$3.42M
10-K · filed 2017-02-24
2014-09-30$854.00K
10-Q · filed 2015-11-05
$1.59M
derived: sum of 2 quarters · filed 2015-11-05
$2.23M
10-Q · filed 2015-11-05
$2.82M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$740.00K
10-Q · filed 2015-08-07
$1.38M
10-Q · filed 2015-08-07
$1.97M
derived: sum of 3 quarters · filed 2016-03-11
$2.49M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$636.00K
10-Q · filed 2015-05-14
$1.23M
derived: sum of 2 quarters · filed 2016-03-11
$1.75M
derived: sum of 3 quarters · filed 2016-03-11
$2.16M
derived: sum of 4 quarters · filed 2016-03-11
2013-12-31$592.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$1.11M
derived: sum of 2 quarters · filed 2016-03-11
$1.52M
derived: sum of 3 quarters · filed 2016-03-11
$2.15M
10-K · filed 2016-03-11
2013-09-30$519.00K
10-Q · filed 2014-11-12
$930.00K
derived: sum of 2 quarters · filed 2014-11-12
$1.55M
10-Q · filed 2014-11-12
$2.04M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30$411.00K
10-Q · filed 2014-08-07
$1.03M
10-Q · filed 2014-08-07
$1.52M
derived: sum of 3 quarters · filed 2015-03-18
$2.01M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31$624.00K
10-Q · filed 2014-05-12
$1.11M
derived: sum of 2 quarters · filed 2015-03-18
$1.60M
derived: sum of 3 quarters · filed 2015-03-18
2012-12-31$484.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
$976.00K
derived: sum of 2 quarters · filed 2015-03-18
$1.72M
10-K · filed 2015-03-18
2012-09-30$492.00K
10-Q · filed 2013-11-13
$1.24M
10-Q · filed 2013-11-13
2011-12-31$2.93M
10-K · filed 2014-03-26